Risk of priapism after dynamic penile Doppler ultrasound: Single-centre experience on a large cohort of patients. [PDF]
AndrologyAbstract Objectives To evaluate the risk of priapism in patients undergoing Dynamic—Penile duplex ultrasound (D‐PDU) who were referred to our Unit between January 2022 and December 2023. Patients and methods We enrolled 292 patients, of whom 268 underwent Dynamic—Penile duplex ultrasound for erectile dysfunction and 24 for Peyronie's disease.
Grande G +6 more
europepmc +2 more sources
The effect of topical and intraurethral alprostadil on erectile function: A systematic review and meta-analysis. [PDF]
AndrologyAbstract Background Erectile dysfunction (ED) affects up to 50% of men over 40. While phosphodiesterase‐5 inhibitors (PDE5i) are the first line of medical treatment, they are not always effective. Alprostadil, available in injectable, topical, and intraurethral forms, offers an alternative treatment modality.
Papadopoulos I +8 more
europepmc +2 more sources
Efficacy and Mechanism of Alprostadil in Diabetes Mellitus Combined with Peripheral Atherosclerosis. [PDF]
Anatol J CardiolYin H, Wan Q.
europepmc +3 more sources
Revista Portuguesa de Cardiologia, 2022 Objectives: Our study aimed to investigate the effects of alprostadil and Salvia miltiorrhiza extract on myocardial ischemia-reperfusion injury (IRI) and related underlying molecular mechanisms.
Jing Liu +8 more
doaj +1 more source
Comparative efficacy of combination therapy including regenerative therapies versus monotherapy for erectile dysfunction: A systematic review and meta-analysis. [PDF]
AndrologyAbstract Background and objective The Current European Association of Urology guidelines do not provide recommendation for combination of regenerative therapies with standard therapies for erectile dysfunction. The aim of this study was to compare the efficacy of combined regenerative therapy with monotherapy for erectile dysfunction.
Quistini A +12 more
europepmc +2 more sources
Frontiers in Cardiovascular Medicine, 2022 BackgroundThe optimum therapy for coronary slow flow phenomenon (CSFP) stays debatable. This study compared the effectiveness of alprostadil with isosorbide dinitrate in alleviating angina episodes in CSFP patients.MethodsIn this prospective, randomized ...
Weifeng Zhang +15 more
doaj +1 more source
Modern aspects of diagnosis and treatment of obliterating atherosclerosis of the lower extremities
Лечащий Врач, 2023 Currently, diseases of the arteries of the lower extremities are an urgent problem of modern medicine, one of the most common variants of peripheral artery diseases.
V. V. Skvortsov +2 more
doaj +1 more source
Frontiers in Medicine, 2023 ObjectiveTo systematically evaluate the clinical efficacy and safety of Shenkang injection (SKI) combined with alprostadil in the treatment of chronic renal failure (CRF).MethodRandomized controlled trials (RCTs) of Shenkang injection combined with ...
Feng Xie +5 more
doaj +1 more source
Journal of Interventional Cardiology, 2023 Background. In-stent restenosis (ISR) is a common complication after percutaneous coronary intervention (PCI) surgery for patients with coronary atherosclerotic heart disease (CHD).
Decai Zhu +5 more
doaj +1 more source
Xuebijing injection combined with alprostadil in the treatment of diabetic nephropathy: A PRISMA-compliant systematic review and meta-analysis. [PDF]
Medicine (Baltimore)Hao N, Liu Y, Guo L, Li W, Zhao P.
europepmc +2 more sources